Sam Roscoe, Lecturer in Operations Management at the University of Sussex writes about the outcome of the knowledge exchange event “The Future of Pharmaceutical Supply Chains”.
Since the 1980s, UK Manufacturing has increasingly moved offshore, with a vast share of goods being produced in countries such as China, India or Bangladesh. Couple this with the fact that any ‘finished’ product will often go through different production stages, each of which can be carried out in various parts of the world, and you are often left with supply chain scenarios that have taken on near absurd scales.
In November 2015 the RiHN team hosted a Special Interest Group in partnership with Medilink . Those who attended had the opportunity to engage with researchers from various institutions who are leading cutting edge feasibility studies that have the potential to radically transform patient care and medical supply chains.